Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Biogen Inc (BIIB)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 24
  • 1 comments

Biogen Completes Acquisition of Alcyone Therapeutics

Market reaction Comment Full text

Entera Bio Ltd. (ENTX)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 24
  • 1 comments

Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates

Market reaction Comment Full text

Coherent Inc (COHR)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 24
  • 1 comments

Coherent Introduces Axon FP – A Breakthrough Fiber-Delivered Femtosecond Laser for Multiphoton Microscopy

Market reaction Comment Full text

4D Molecular Therapeutics (FDMT)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 15
  • 1 comments

4DMT Announces New Employment Inducement Grants

Market reaction Comment Full text

Verrica Pharmaceuticals (VRCA)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 29
  • 1 comments

Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results

Market reaction Comment Full text

Evolus Inc (EOLS)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 24
  • 1 comments

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Dermata Therapeutics Inc. (DRMA)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 22
  • 1 comments

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Market reaction Comment Full text

Enveric Biosciences Inc. (ENVB)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 21
  • 1 comments

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

Market reaction Comment Full text

Terns Pharmaceuticals Inc (TERN)

  • Business News
  • Nov. 14, 2025, 21:05 UTC
  • 24
  • 1 comments

Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London

Market reaction Comment Full text

Nuvalent Inc (NUVL)

  • Business News
  • Nov. 14, 2025, 21:03 UTC
  • 10
  • 0 comments

Nuvalent Announces Timing of Topline Pivotal Data for TKI Pre-treated Patients with Advanced ALK-positive NSCLC from ALKOVE-1 Clinical Trial of Neladalkib

Market reaction Comment Full text
  • Previous
  • 615
  • 616
  • 617
  • 618
  • 619
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2406)
  • SEC News(192204)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125467)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin